Scientists have a strong idea of which types of viruses could cause an outbreak. We can fund vaccines and treatments for them now.
A team of University of Washington School of Public Health students received the Exceptional Student Award from the Washington State Public Health Association (WSPHA) for their work supporting the COVID-19 outbreak response in North Central Washington.
CHICAGO, Nov 3 (Reuters) - As the devastating Delta variant surge eases in many regions of the world, scientists are charting when, and where, COVID-19 will transition to an endemic disease in 2022 and beyond, according to Reuters interviews with over a dozen leading disease experts.
Image Credit: REUTERS/Tatyana Makeyeva
COVID-19 In-Depth Report: Summary of Evidence Related to Travel, Hospitality and Service Industries, and COVID-19 Risk
Prior to the COVID-19 pandemic, travel was a large part of most individuals’ lives – whether it was for work, leisure, or to visit family. Pre-departure and post-arrival testing and quarantining have become major public health surveillance components of traveling in the last year.
‘People Were Really Quite Stunned’: Dr. Caroline Ryan, Incoming CDC Country Director for Ethiopia, Shares Lessons from the Fight Against HIV, COVID-19 in Eswatini
When Dr. Caroline Ryan became the CDC Country Director for Eswatini in 2015, the small kingdom in Southern Africa (then known as Swaziland) had the highest rate of HIV in the world – 27% of the adult population. But there was reason to be optimistic.
The following year, a study showed that the number of new infections in the country had been nearly halved and the number of people who were on antiretrovirals that were virally suppressed had doubled.
COVID-19 In-Depth Report: Summary of Evidence Related to the Risk of Other Infections in the Context of COVID-19
Severe COVID-19 is associated with critical illness and immune dysregulation, both of which have been previously associated with increased risk of nosocomial infection. The care of COVID-19 patients has required dramatic changes to usual hospital practices and heightened concern for infection control practices. This is a brief summary of published evidence related to the effect of the COVID-19 pandemic on non-COVID infections.
Double Dose of Debate: Opinions Vary on Timing of COVID Vaccine Shots as Potential 4th Wave Looms (includes Ruanne Barnabas)
With COVID-19 vaccines still in limited supply and case counts threatening to resurge, there is a debate over the benefits of giving more people their first shot and waiting a longer time to administer the second dose, or whether to stay the course and prioritize getting both doses of the Pfizer and Moderna vaccine into arms as quickly as possible.
Enrollment for UW students, faculty and staff is open for the Husky Coronavirus Testing.
See UW Medicine's COVID-19 Vaccines guide.
We remain committed to providing a high-quality Husky Experience for every student, supporting the University of Washington’s vital research and service missions, and continuing to provide the outstanding medical care that keeps our community healthy.
At just over one year into the COVID-19 pandemic, evolution of SARS-CoV-2 has generated viral variants that differ in their genetic sequence from the strain first detected in December 2019. Evidence is emerging about how these variants differ in their transmission characteristics, associated clinical symptoms, and vaccine efficacy. This document is a brief summary of published evidence about characteristics of SARS-CoV-2 variants that may impact the public health response, including transmission and response to vaccination.